当前位置:科学网首页 > 小柯机器人 >详情
SHP-2和PD-1-SHP-2信号传递调节骨髓细胞分化和抗肿瘤反应
作者:小柯机器人 发布时间:2022/12/31 23:15:56

美国哈佛医学院Vassiliki A. Boussiotis研究组发现,SHP-2和PD-1-SHP-2信号传递调节骨髓细胞分化和抗肿瘤反应。相关论文于2022年12月29日在线发表于国际学术期刊《自然—免疫学》上。

研究人员表明,在骨髓细胞中条件性靶向SHP-2的小鼠,而不是在T细胞中靶向SHP-2的小鼠,肿瘤生长会被减弱。RNA测序(RNA-seq)和基因集富集分析表明了多形核骨髓源性抑制细胞和肿瘤相关巨噬细胞(TAM)的存在,其富集的基因表达谱表明分化、激活和免疫刺激分子的表达增强。在骨髓细胞中对PD-1进行条件性靶向的小鼠中,也显示出肿瘤生长的减弱,TAM的基因富集分析富含骨髓分化、激活和白细胞介导的免疫力,与SHP-2缺陷TAM的富集分析重合度>50%。
 
在骨髓中,GM-CSF诱导了PD-1的磷酸化和PD-1-SHP-2对GM-CSF受体的招募。SHP-2或PD-1的缺失增强了GM-CSF介导的转录因子HOXA10和IRF8的磷酸化,这两个因子分别调节骨髓分化和单核细胞-巨核细胞谱系确立。因此,SHP-2和PD-1-SHP-2信号抑制了骨髓细胞的分化,并造成了抑制抗肿瘤免疫的骨髓状态。
 
据了解,抑制性受体PD-1通过招募磷酸酶SHP-2来抑制T细胞的激活。然而,T细胞特异性缺失SHP-2的小鼠并没有改善抗肿瘤免疫力。
 
附:英文原文

Title: SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses

Author: Christofides, Anthos, Katopodi, Xanthi-Lida, Cao, Carol, Karagkouni, Dimitra, Aliazis, Konstantinos, Yenyuwadee, Sasitorn, Aksoylar, Halil-Ibrahim, Pal, Rinku, Mahmoud, Mohamed A. A., Strauss, Laura, Tijaro-Ovalle, Natalia M., Boon, Louis, Asara, John, Vlachos, Ioannis S., Patsoukis, Nikolaos, Boussiotis, Vassiliki A.

Issue&Volume: 2022-12-29

Abstract: The inhibitory receptor PD-1 suppresses T cell activation by recruiting the phosphatase SHP-2. However, mice with a T-cell-specific deletion of SHP-2 do not have improved antitumor immunity. Here we showed that mice with conditional targeting of SHP-2 in myeloid cells, but not in T cells, had diminished tumor growth. RNA sequencing (RNA-seq) followed by gene set enrichment analysis indicated the presence of polymorphonuclear myeloid-derived suppressor cells and tumor-associated macrophages (TAMs) with enriched gene expression profiles of enhanced differentiation, activation and expression of immunostimulatory molecules. In mice with conditional targeting of PD-1 in myeloid cells, which also displayed diminished tumor growth, TAMs had gene expression profiles enriched for myeloid differentiation, activation and leukocyte-mediated immunity displaying >50% overlap with enriched profiles of SHP-2-deficient TAMs. In bone marrow, GM-CSF induced the phosphorylation of PD-1 and recruitment of PD-1-SHP-2 to the GM-CSF receptor. Deletion of SHP-2 or PD-1 enhanced GM-CSF-mediated phosphorylation of the transcription factors HOXA10 and IRF8, which regulate myeloid differentiation and monocytic-moDC lineage commitment, respectively. Thus, SHP-2 and PD-1-SHP-2 signaling restrained myelocyte differentiation resulting in a myeloid landscape that suppressed antitumor immunity.

DOI: 10.1038/s41590-022-01385-x

Source: https://www.nature.com/articles/s41590-022-01385-x

期刊信息

Nature Immunology:《自然—免疫学》,创刊于2000年。隶属于施普林格·自然出版集团,最新IF:31.25
官方网址:https://www.nature.com/ni/
投稿链接:https://mts-ni.nature.com/cgi-bin/main.plex